PATH
Seattle, Washington, United States
Purpose
to advance clinical development of a late-stage rotavirus vaccine candidate by a developing-country manufacturer, ultimately increasing affordability and access to sustainable rotavirus vaccine introduction in low-resource settings; and to
Division
Global Health
Date
November 2010
Region Served
AMERICA, ASIA, EUROPE
Committed amount
$31,692,704
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
163
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.